MyJournals Home  

RSS FeedsAn economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care (Pharmacogenomics Journal)

 
 

18 january 2019 07:00:12

 
An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care (Pharmacogenomics Journal)
 




 
227 viewsCategory: Genomics, Pharmacology
 
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure (Pharmacogenomics Journal)
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients - a randomized, prospective study (Pharmacogenomics Journal)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten